An experimental Covid -19 vaccine developed by Sanofi and Britain's GlaxoSmithKline showed an insufficient immune response in clinical trial results, the French drugmaker said on Friday, a blow to efforts to fight the pandemic. The two companies said they planned to launch another study next year, hoping to come up with a more effective vaccine by the end of 2021.
Luggage
Carts 
Luggage
Locks
Luggage
Scales
Luggage
Straps
Luggage Tags
Handle
Wraps
Packing
Organizers
Passport
Wallets
Shoe Bags
Toiletry
Bags
Travel Bottles & Containers 
Earplugs
Keyrings & Keychains 
Luggage
Accessories
Money
Clips
Sleep
Masks
Travel
Blankets
Travel Kits & Organizers
Travel
Lights
Umbrellas
Luggage
Locks
Luggage
Scales
Luggage
Straps
Luggage Tags
Handle
Wraps
Packing
Organizers
Passport
Wallets
Shoe Bags
Toiletry
Bags
Travel Bottles & Containers 
Earplugs
Keyrings & Keychains 
Luggage
Accessories
Money
Clips
Sleep
Masks
Travel
Blankets
Travel Kits & Organizers
Travel
Lights
Umbrellas
Friday, December 11, 2020
Sanofi/GSK announce delay in Covid-19 vaccine project December 10, 2020 at 10:11PM
An experimental Covid -19 vaccine developed by Sanofi and Britain's GlaxoSmithKline showed an insufficient immune response in clinical trial results, the French drugmaker said on Friday, a blow to efforts to fight the pandemic. The two companies said they planned to launch another study next year, hoping to come up with a more effective vaccine by the end of 2021.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment